LXEO
Lexeo Therapeutics, Inc.After hours2.63−0.11 −4.01%USD
NasdaqGM · as of Oct 14, 16:00 ET · 15m delayAfter hours 2.60 −1.14%
Open
2.70
Prev close
2.74
Day range
2.562.79
52-week range
2.5610.99
Volume
1.92M1.57×
Mkt cap
215.89M
P/E ttm
—
Fwd P/E
-1.93
EPS ttm
-1.02
Div yield
0.00%
Earnings
Aug 12, 2026
From 52w high
−76.07%
LXEO shareholders
LXEO Ownership
13F / N-PORT filings via Yahoo
Institutions
114.7%
115.4% of the float
Insiders
0.6%
officers and directors
Institutional holders
186
filing positions
Top 10 institutions
59.1%
7 adding · 2 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| Montanova Capital LLC | 7.78% | 6.38M | $16.79M | +410.7% | Jun 30, 2026 |
| Affinity Asset Advisors, Llc | 7.08% | 5.81M | $15.27M | +15.0% | Jun 30, 2026 |
| Blackrock Inc. | 7.00% | 5.74M | $15.09M | +12.3% | Jun 30, 2026 |
| RA Capital Management, L.P. | 6.09% | 5.00M | $13.15M | 0.0% | Jun 30, 2026 |
| Frazier Life Sciences Management, L.P. | 5.88% | 4.82M | $12.69M | +9.0% | Jun 30, 2026 |
| State Street Corporation | 5.31% | 4.35M | $11.45M | +22.0% | Jun 30, 2026 |
| Vestal Point Capital, LP | 5.27% | 4.32M | $11.36M | −3.5% | Jun 30, 2026 |
| Paradigm Biocapital Advisors LP | 5.09% | 4.18M | $10.98M | −32.5% | Jun 30, 2026 |
| Jupiter Topco LLC | 4.82% | 3.95M | $10.40M | +100.0% | Jun 30, 2026 |
| Orbimed Advisors LLC. | 4.81% | 3.95M | $10.38M | +9.6% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.13% | 2.56M | $6.75M | +7.5% | Aug 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.85% | 2.34M | $6.14M | +3.4% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.22% | 1.82M | $4.78M | +0.7% | Aug 31, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.95% | 776.53K | $2.04M | +0.9% | Jul 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.87% | 715.41K | $1.88M | +6.5% | Jun 30, 2026 |
| abrdn Life Sciences Investors | 0.82% | 675.09K | $1.78M | +174.5% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 Value ETF | 0.80% | 658.23K | $1.73M | +0.5% | Aug 31, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 0.68% | 561.26K | $1.48M | −11.4% | Jun 30, 2026 |
| SPDR SERIES TRT-State Street SPDR S&P Kensho New Economies Composite E | 0.68% | 561.91K | $1.48M | −0.8% | Aug 31, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.56% | 459.62K | $1.21M | +2.5% | Aug 31, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).